Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells

References

• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119:1420 - 8; http://dx.doi.org/10.1172/JCI39104; PMID: 19487818
   PubMed Web of Science ®Google Scholar
• Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Bröcker EB, Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003; 160:267 - 77; http://dx.doi.org/10.1083/jcb.200209006; PMID: 12527751
   PubMed Web of Science ®Google Scholar
• Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003; 5:711 - 9; http://dx.doi.org/10.1038/ncb1019; PMID: 12844144
   PubMed Web of Science ®Google Scholar
• Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010; 188:11 - 9; http://dx.doi.org/10.1083/jcb.200909003; PMID: 19951899
   PubMed Web of Science ®Google Scholar
• Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K, Canzonieri V, D’Andrea S, Zucchetto A, Friedl P, et al. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 2008; 19:2003 - 13; http://dx.doi.org/10.1091/mbc.E07-09-0894; PMID: 18305103
   PubMed Web of Science ®Google Scholar
• Shea KF, Wells CM, Garner AP, Jones GE. ROCK1 and LIMK2 interact in spread but not blebbing cancer cells. PLoS One 2008; 3:e3398; http://dx.doi.org/10.1371/journal.pone.0003398; PMID: 18852895
   PubMedGoogle Scholar
• Yoshida K, Soldati T. Dissection of amoeboid movement into two mechanically distinct modes. J Cell Sci 2006; 119:3833 - 44; http://dx.doi.org/10.1242/jcs.03152; PMID: 16926192
   PubMed Web of Science ®Google Scholar
• Eisenmann KM, Harris ES, Kitchen SM, Holman HA, Higgs HN, Alberts AS. Dia-interacting protein modulates formin-mediated actin assembly at the cell cortex. Curr Biol 2007; 17:579 - 91; http://dx.doi.org/10.1016/j.cub.2007.03.024; PMID: 17398099
   PubMed Web of Science ®Google Scholar
• Fackler OT, Grosse R. Cell motility through plasma membrane blebbing. J Cell Biol 2008; 181:879 - 84; http://dx.doi.org/10.1083/jcb.200802081; PMID: 18541702
   PubMed Web of Science ®Google Scholar
• Di Vizio D, Morello M, Dudley AC, Schow PW, Adam RM, Morley S, Mulholland D, Rotinen M, Hager MH, Insabato L, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 2012; 181:1573 - 84; http://dx.doi.org/10.1016/j.ajpath.2012.07.030; PMID: 23022210
   PubMed Web of Science ®Google Scholar
• Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 2012; 21:R1 R125 - 34; http://dx.doi.org/10.1093/hmg/dds317; PMID: 22872698
   PubMed Web of Science ®Google Scholar
• Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010; 123:1603 - 11; http://dx.doi.org/10.1242/jcs.064386; PMID: 20445011
   PubMed Web of Science ®Google Scholar
• Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, Oeh J, Modrusan Z, Bais C, Sampath D, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J 2012; 31:3513 - 23; http://dx.doi.org/10.1038/emboj.2012.183; PMID: 22773185
   PubMed Web of Science ®Google Scholar
• Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B, Camussi G. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110:2440 - 8; http://dx.doi.org/10.1182/blood-2007-03-078709; PMID: 17536014
   PubMed Web of Science ®Google Scholar
• Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 2012; 109:E2110 - 6; http://dx.doi.org/10.1073/pnas.1209414109; PMID: 22753494
   PubMed Web of Science ®Google Scholar
• Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, Grau GE. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 2009; 23:1643 - 9; http://dx.doi.org/10.1038/leu.2009.76; PMID: 19369960
   PubMed Web of Science ®Google Scholar
• Rak J, Guha A. Extracellular vesicles--vehicles that spread cancer genes. Bioessays 2012; 34:489 - 97; http://dx.doi.org/10.1002/bies.201100169; PMID: 22442051
   PubMed Web of Science ®Google Scholar
• Hager MH, Morley S, Bielenberg DR, Gao S, Morello M, Holcomb IN, Liu W, Mouneimne G, Demichelis F, Kim J, et al. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype. EMBO Mol Med 2012; 4:743 - 60; http://dx.doi.org/10.1002/emmm.201200242; PMID: 22593025
   PubMed Web of Science ®Google Scholar
• Goode BL, Eck MJ. Mechanism and function of formins in the control of actin assembly. Annu Rev Biochem 2007; 76:593 - 627; http://dx.doi.org/10.1146/annurev.biochem.75.103004.142647; PMID: 17373907
   PubMed Web of Science ®Google Scholar
• Breitsprecher D, Goode BL. Formins at a glance. J Cell Sci 2013; 126:1 - 7; http://dx.doi.org/10.1242/jcs.107250; PMID: 23516326
   PubMed Web of Science ®Google Scholar
• Thurston SF, Kulacz WA, Shaikh S, Lee JM, Copeland JW. The ability to induce microtubule acetylation is a general feature of formin proteins. PLoS One 2012; 7:e48041; http://dx.doi.org/10.1371/journal.pone.0048041; PMID: 23110170
   PubMed Web of Science ®Google Scholar
• Bartolini F, Gundersen GG. Formins and microtubules. Biochim Biophys Acta 2010; 1803:164 - 73; http://dx.doi.org/10.1016/j.bbamcr.2009.07.006; PMID: 19631698
   PubMed Web of Science ®Google Scholar
• Di Vizio D, Kim J, Hager MH, Morello M, Yang W, Lafargue CJ, True LD, Rubin MA, Adam RM, Beroukhim R, et al. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 2009; 69:5601 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-08-3860; PMID: 19549916
   PubMed Web of Science ®Google Scholar
• Freeman MR, Paul S, Kaefer M, Ishikawa M, Adam RM, Renshaw AA, Elenius K, Klagsbrun M. Heparin-binding EGF-like growth factor in the human prostate: synthesis predominantly by interstitial and vascular smooth muscle cells and action as a carcinoma cell mitogen. J Cell Biochem 1998; 68:328 - 38; http://dx.doi.org/10.1002/(SICI)1097-4644(19980301)68:3<328::AID-JCB4>3.0.CO;2-W; PMID: 9518259
   PubMed Web of Science ®Google Scholar
• Kim J, Adam RM, Freeman MR. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation. Cancer Res 2002; 62:1549 - 54; PMID: 11888934
   PubMed Web of Science ®Google Scholar
• Lin J, Adam RM, Santiestevan E, Freeman MR. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res 1999; 59:2891 - 7; PMID: 10383151
   PubMed Web of Science ®Google Scholar
• Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D’Souza-Schorey C. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 2009; 19:1875 - 85; http://dx.doi.org/10.1016/j.cub.2009.09.059; PMID: 19896381
   PubMed Web of Science ®Google Scholar
• Kim J, Keay SK, Freeman MR. Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation. BJU Int 2009; 103:541 - 6; http://dx.doi.org/10.1111/j.1464-410X.2008.08097.x; PMID: 18990151
   PubMed Web of Science ®Google Scholar
• Dong QZ, Wang Y, Tang ZP, Fu L, Li QC, Wang ED, Wang EH. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am J Pathol 2013; 182:954 - 64; http://dx.doi.org/10.1016/j.ajpath.2012.11.019; PMID: 23306155
   PubMed Web of Science ®Google Scholar
• Xiao LJ, Lin P, Lin F, Liu X, Qin W, Zou HF, Guo L, Liu W, Wang SJ, Yu XG. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol 2012; 40:1714 - 24; PMID: 22200661
   PubMed Web of Science ®Google Scholar
• Li B, Antonyak MA, Zhang J, Cerione RA. RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 2012; 31:4740 - 9; http://dx.doi.org/10.1038/onc.2011.636; PMID: 22266864
   PubMed Web of Science ®Google Scholar
• Wegiel B, Evans S, Hellsten R, Otterbein LE, Bjartell A, Persson JL. Molecular pathways in the progression of hormone-independent and metastatic prostate cancer. Curr Cancer Drug Targets 2010; 10:392 - 401; http://dx.doi.org/10.2174/156800910791208562; PMID: 20384583
   PubMed Web of Science ®Google Scholar
• Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G, Yang Q. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene 2013; Forthcoming http://dx.doi.org/10.1038/onc.2013.286; PMID: 23851509
   PubMed Web of Science ®Google Scholar
• Valastyan S. Roles of microRNAs and other non-coding RNAs in breast cancer metastasis. J Mammary Gland Biol Neoplasia 2012; 17:23 - 32; http://dx.doi.org/10.1007/s10911-012-9241-9; PMID: 22293951
   PubMed Web of Science ®Google Scholar
• Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11:252 - 63; http://dx.doi.org/10.1038/nrm2868; PMID: 20216554
   PubMed Web of Science ®Google Scholar
• Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Sarkar FH. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009; 27:1712 - 21; http://dx.doi.org/10.1002/stem.101; PMID: 19544444
   PubMed Web of Science ®Google Scholar
• Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci U S A 2007; 104:19983 - 8; http://dx.doi.org/10.1073/pnas.0706641104; PMID: 18056640
   PubMed Web of Science ®Google Scholar
• Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 2011; 71:538 - 49; http://dx.doi.org/10.1002/pros.21270; PMID: 20886540
   PubMed Web of Science ®Google Scholar
• Duque JL, Adam RM, Mullen JS, Lin J, Richie JP, Freeman MR. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro. J Urol 2001; 165:284 - 8; http://dx.doi.org/10.1097/00005392-200101000-00080; PMID: 11125426
   PubMed Web of Science ®Google Scholar
• Lee TH, D’Asti E, Magnus N, Al-Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular ‘debris’. Semin Immunopathol 2011; 33:455 - 67; http://dx.doi.org/10.1007/s00281-011-0250-3; PMID: 21318413
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, Meehan B, Micallef J, Lhotak V, May L, Guha A, Rak J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008; 10:619 - 24; http://dx.doi.org/10.1038/ncb1725; PMID: 18425114
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 2009; 106:3794 - 9; http://dx.doi.org/10.1073/pnas.0804543106; PMID: 19234131
   PubMed Web of Science ®Google Scholar
• Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2011; 2:180; http://dx.doi.org/10.1038/ncomms1180; PMID: 21285958
   PubMed Web of Science ®Google Scholar
• Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, Hochberg FH, Breakefield XO, Carter BS, Skog J. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 2012; 12:22; http://dx.doi.org/10.1186/1471-2407-12-22; PMID: 22251860
   PubMed Web of Science ®Google Scholar
• Camussi G, Deregibus MC, Tetta C. Tumor-derived microvesicles and the cancer microenvironment. Curr Mol Med 2013; 13:58 - 67; http://dx.doi.org/10.2174/156652413804486304; PMID: 22834836
   PubMed Web of Science ®Google Scholar
• D’Souza-Schorey C, Clancy JW. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012; 26:1287 - 99; http://dx.doi.org/10.1101/gad.192351.112; PMID: 22713869
   PubMed Web of Science ®Google Scholar
• Filipazzi P, Bürdek M, Villa A, Rivoltini L, Huber V. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol 2012; 22:342 - 9; http://dx.doi.org/10.1016/j.semcancer.2012.02.005; PMID: 22369922
   PubMed Web of Science ®Google Scholar
• Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18:883 - 91; http://dx.doi.org/10.1038/nm.2753; PMID: 22635005
   PubMed Web of Science ®Google Scholar
• Hannemann S, Madrid R, Stastna J, Kitzing T, Gasteier J, Schönichen A, Bouchet J, Jimenez A, Geyer M, Grosse R, et al. The Diaphanous-related Formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing. J Biol Chem 2008; 283:27891 - 903; http://dx.doi.org/10.1074/jbc.M801800200; PMID: 18694941
   PubMed Web of Science ®Google Scholar
• Kitzing TM, Sahadevan AS, Brandt DT, Knieling H, Hannemann S, Fackler OT, Grosshans J, Grosse R. Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion. Genes Dev 2007; 21:1478 - 83; http://dx.doi.org/10.1101/gad.424807; PMID: 17575049
   PubMed Web of Science ®Google Scholar
• Kitzing TM, Wang Y, Pertz O, Copeland JW, Grosse R. Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. Oncogene 2010; 29:2441 - 8; http://dx.doi.org/10.1038/onc.2009.515; PMID: 20101212
   PubMed Web of Science ®Google Scholar
• Wyse MM, Lei J, Nestor-Kalinoski AL, Eisenmann KM. Dia-interacting protein (DIP) imposes migratory plasticity in mDia2-dependent tumor cells in three-dimensional matrices. PLoS One 2012; 7:e45085; http://dx.doi.org/10.1371/journal.pone.0045085; PMID: 23024796
   PubMedGoogle Scholar
• Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10:593 - 601; http://dx.doi.org/10.1038/ncb1722; PMID: 18376396
   PubMed Web of Science ®Google Scholar
• Elson-Schwab I, Lorentzen A, Marshall CJ. MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 2010; 5:e13176; http://dx.doi.org/10.1371/journal.pone.0013176; PMID: 20957176
   PubMedGoogle Scholar
• Walter BA, Valera VA, Pinto PA, Merino MJ. Comprehensive microRNA Profiling of Prostate Cancer. J Cancer 2013; 4:350 - 7; http://dx.doi.org/10.7150/jca.6394; PMID: 23781281
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Barnes S, Grizzle W, Miller D, Zhang HG. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 2010; 18:1606 - 14; http://dx.doi.org/10.1038/mt.2010.105; PMID: 20571541
   PubMed Web of Science ®Google Scholar
• van Dommelen SM, Vader P, Lakhal S, Kooijmans SA, van Solinge WW, Wood MJ, Schiffelers RM. Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release 2012; 161:635 - 44; http://dx.doi.org/10.1016/j.jconrel.2011.11.021; PMID: 22138068
   PubMed Web of Science ®Google Scholar
• EL Andaloussi S, Mäger I, Breakefield XO, Wood MJ, S ELA. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 2013; 12:347 - 57; http://dx.doi.org/10.1038/nrd3978; PMID: 23584393
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006; 1:297 - 315; PMID: 17717971
   PubMed Web of Science ®Google Scholar
• Kooijmans SA, Vader P, van Dommelen SM, van Solinge WW, Schiffelers RM. Exosome mimetics: a novel class of drug delivery systems. Int J Nanomedicine 2012; 7:1525 - 41; PMID: 22619510
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans 2013; 41:245 - 51; http://dx.doi.org/10.1042/BST20120265; PMID: 23356291
   PubMed Web of Science ®Google Scholar
• Kim J, Kim WJ, Liu Z, Loda M, Freeman MR. The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle 2012; 11:1123 - 30; http://dx.doi.org/10.4161/cc.11.6.19550; PMID: 22370483
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay NK, Kim J, Cinar B, Ramachandran A, Hager MH, Di Vizio D, Adam RM, Rubin MA, Raychaudhuri P, De Benedetti A, et al. Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. Cancer Res 2009; 69:2210 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-08-2308; PMID: 19258514
   PubMed Web of Science ®Google Scholar
• Kim J, Jahng WJ, Di Vizio D, Lee JS, Jhaveri R, Rubin MA, Shisheva A, Freeman MR. The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res 2007; 67:9229 - 37; http://dx.doi.org/10.1158/0008-5472.CAN-07-1333; PMID: 17909029
   PubMed Web of Science ®Google Scholar
• Bedoret D, Singh AK, Shaw V, Hoyte EG, Hamilton R, DeKruyff RH, Schneider LC, Nadeau KC, Umetsu DT. Changes in antigen-specific T-cell number and function during oral desensitization in cow’s milk allergy enabled with omalizumab. Mucosal Immunol 2012; 5:267 - 76; http://dx.doi.org/10.1038/mi.2012.5; PMID: 22318492
   PubMed Web of Science ®Google Scholar